Lista de obras - Brett W Stringer - Dominio Público Uruguay

A metabolic shift favoring sphingosine 1-phosphate at the expense of ceramide controls glioblastoma angiogenesis.

artículo científico publicado en 2013

A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastoma

article

A unique 19F MRI agent for the tracking of non phagocytic cells in vivo

artículo científico publicado en 2018

Anti-GD2-ch14.18/CHO coated nanoparticles mediate glioblastoma (GBM)-specific delivery of the aromatase inhibitor, Letrozole, reducing proliferation, migration and chemoresistance in patient-derived GBM tumor cells

artículo científico publicado en 2017

Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake.

artículo científico publicado en 2013

Changes in cell morphology guide identification of tubulin as the off-target for protein kinase inhibitors

Cyclin-dependent kinase 7 is a therapeutic target in high-grade glioma.

artículo científico publicado en 2017

Cytoplasmic dynein regulates the subcellular localization of sphingosine kinase 2 to elicit tumor-suppressive functions in glioblastoma

artículo científico publicado en 2019

DNase I hypersensitive sites in the 5' flanking region of the human plasminogen activator inhibitor type 2 (PAI-2) gene are associated with basal and tumor necrosis factor-alpha-induced transcription in monocytes

artículo científico publicado en 1998

Development and Biological Evaluation of a Photoactivatable Small Molecule Microtubule-Targeting Agent

artículo científico publicado en 2017

Dianthin-30 or gelonin versus monomethyl auristatin E, each configured with an anti-calcitonin receptor antibody, are differentially potent in vitro in high-grade glioma cell lines derived from glioblastoma

artículo científico publicado en 2017

Differential response of patient-derived primary glioblastoma cells to environmental stiffness

artículo científico publicado en 2016

ELK4 neutralization sensitizes glioblastoma to apoptosis through downregulation of the anti-apoptotic protein Mcl-1

artículo científico publicado en 2011

Eph family co-expression patterns define unique clusters predictive of cancer phenotype

artículo científico publicado en 2014

Eph receptors as therapeutic targets in glioblastoma

artículo científico publicado en 2014

EphA3 Pay-Loaded Antibody Therapeutics for the Treatment of Glioblastoma

artículo científico publicado en 2018

EphA3 as a target for antibody immunotherapy in acute lymphoblastic leukemia

artículo científico publicado en 2016

EphA3 maintains tumorigenicity and is a therapeutic target in glioblastoma multiforme.

artículo científico publicado en 2013

Ephrin expression and function in cancer.

artículo científico publicado en 2010

Expression and activity of the calcitonin receptor family in a sample of primary human high-grade gliomas

artículo científico publicado en 2019

Extracellular Vesicles Released by Glioblastoma Cells Stimulate Normal Astrocytes to Acquire a Tumor-Supportive Phenotype Via p53 and MYC Signaling Pathways

artículo científico publicado en 2018

Increased sensitivity to ionizing radiation by targeting the homologous recombination pathway in glioma initiating cells.

artículo científico publicado en 2014

Inhibition of retinoblastoma protein degradation by interaction with the serpin plasminogen activator inhibitor 2 via a novel consensus motif

artículo científico publicado en 2003

Intratumoural Heterogeneity Underlies Distinct Therapy Responses and Treatment Resistance in Glioblastoma

article

NFIB-mediated repression of the epigenetic factor Ezh2 regulates cortical development

artículo científico publicado en 2014

Neurosphere and adherent culture conditions are equivalent for malignant glioma stem cell lines

artículo científico publicado en 2015

Novel dual-action prodrug triggers apoptosis in glioblastoma cells by releasing a glutathione quencher and lysine-specific histone demethylase 1A inhibitor

scientific article published on 03 February 2019

Nuclear factor one B (NFIB) encodes a subtype-specific tumour suppressor in glioblastoma

artículo científico publicado en 2016

Patient-derived glioblastoma cells show significant heterogeneity in treatment responses to the inhibitor-of-apoptosis-protein antagonist birinapant

artículo científico publicado en 2015

Pharmacology of novel small-molecule tubulin inhibitors in glioblastoma cells with enhanced EGFR signalling

artículo científico publicado en 2015

Publisher Correction: A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastoma

artículo científico publicado en 2020

Regulation of the human plasminogen activator inhibitor type 2 gene: cooperation of an upstream silencer and transactivator.

artículo científico publicado en 2012

SRRM4 Expands the Repertoire of Circular RNAs by Regulating Microexon Inclusion

artículo científico publicado en 2020

Structural Optimization and Pharmacological Evaluation of Inhibitors Targeting Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases (DYRK) and CDC-like kinases (CLK) in Glioblastoma.

artículo científico publicado en 2017

The Suitability of Glioblastoma Cell Lines as Models for Primary Glioblastoma Cell Metabolism

artículo científico publicado en 2020

The effect of valproic acid in combination with irradiation and temozolomide on primary human glioblastoma cells

artículo científico publicado en 2015

The glycosylphosphatidylinositol-anchored serine protease PRSS21 (testisin) imparts murine epididymal sperm cell maturation and fertilizing ability.

artículo científico publicado en 2009

The transcription factor C/EBP-β mediates constitutive and LPS-inducible transcription of murine SerpinB2.

artículo científico publicado en 2013

The tumor suppressor microRNA, miR-124a, is regulated by epigenetic silencing and by the transcriptional factor, REST in glioblastoma

artículo científico publicado en 2013

Tropomyosin Tpm 2.1 loss induces glioblastoma spreading in soft brain-like environments

artículo científico publicado en 2018

Using the apparent diffusion coefficient to identifying MGMT promoter methylation status early in glioblastoma: importance of analytical method

artículo científico publicado en 2015

Lista de obras de Brett W Stringer

A metabolic shift favoring sphingosine 1-phosphate at the expense of ceramide controls glioblastoma angiogenesis.

A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastoma

A unique 19F MRI agent for the tracking of non phagocytic cells in vivo

Anti-GD2-ch14.18/CHO coated nanoparticles mediate glioblastoma (GBM)-specific delivery of the aromatase inhibitor, Letrozole, reducing proliferation, migration and chemoresistance in patient-derived GBM tumor cells

Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake.

Changes in cell morphology guide identification of tubulin as the off-target for protein kinase inhibitors

Cyclin-dependent kinase 7 is a therapeutic target in high-grade glioma.

Cytoplasmic dynein regulates the subcellular localization of sphingosine kinase 2 to elicit tumor-suppressive functions in glioblastoma

DNase I hypersensitive sites in the 5' flanking region of the human plasminogen activator inhibitor type 2 (PAI-2) gene are associated with basal and tumor necrosis factor-alpha-induced transcription in monocytes

Development and Biological Evaluation of a Photoactivatable Small Molecule Microtubule-Targeting Agent

Dianthin-30 or gelonin versus monomethyl auristatin E, each configured with an anti-calcitonin receptor antibody, are differentially potent in vitro in high-grade glioma cell lines derived from glioblastoma

Differential response of patient-derived primary glioblastoma cells to environmental stiffness

ELK4 neutralization sensitizes glioblastoma to apoptosis through downregulation of the anti-apoptotic protein Mcl-1

Eph family co-expression patterns define unique clusters predictive of cancer phenotype

Eph receptors as therapeutic targets in glioblastoma

EphA3 Pay-Loaded Antibody Therapeutics for the Treatment of Glioblastoma

EphA3 as a target for antibody immunotherapy in acute lymphoblastic leukemia

EphA3 maintains tumorigenicity and is a therapeutic target in glioblastoma multiforme.

Ephrin expression and function in cancer.

Expression and activity of the calcitonin receptor family in a sample of primary human high-grade gliomas

Extracellular Vesicles Released by Glioblastoma Cells Stimulate Normal Astrocytes to Acquire a Tumor-Supportive Phenotype Via p53 and MYC Signaling Pathways

Increased sensitivity to ionizing radiation by targeting the homologous recombination pathway in glioma initiating cells.

Inhibition of retinoblastoma protein degradation by interaction with the serpin plasminogen activator inhibitor 2 via a novel consensus motif

Intratumoural Heterogeneity Underlies Distinct Therapy Responses and Treatment Resistance in Glioblastoma

NFIB-mediated repression of the epigenetic factor Ezh2 regulates cortical development

Neurosphere and adherent culture conditions are equivalent for malignant glioma stem cell lines

Novel dual-action prodrug triggers apoptosis in glioblastoma cells by releasing a glutathione quencher and lysine-specific histone demethylase 1A inhibitor

Nuclear factor one B (NFIB) encodes a subtype-specific tumour suppressor in glioblastoma

Patient-derived glioblastoma cells show significant heterogeneity in treatment responses to the inhibitor-of-apoptosis-protein antagonist birinapant

Pharmacology of novel small-molecule tubulin inhibitors in glioblastoma cells with enhanced EGFR signalling

Publisher Correction: A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastoma

Regulation of the human plasminogen activator inhibitor type 2 gene: cooperation of an upstream silencer and transactivator.

SRRM4 Expands the Repertoire of Circular RNAs by Regulating Microexon Inclusion

Structural Optimization and Pharmacological Evaluation of Inhibitors Targeting Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases (DYRK) and CDC-like kinases (CLK) in Glioblastoma.

The Suitability of Glioblastoma Cell Lines as Models for Primary Glioblastoma Cell Metabolism

The effect of valproic acid in combination with irradiation and temozolomide on primary human glioblastoma cells

The glycosylphosphatidylinositol-anchored serine protease PRSS21 (testisin) imparts murine epididymal sperm cell maturation and fertilizing ability.

The transcription factor C/EBP-β mediates constitutive and LPS-inducible transcription of murine SerpinB2.

The tumor suppressor microRNA, miR-124a, is regulated by epigenetic silencing and by the transcriptional factor, REST in glioblastoma

Tropomyosin Tpm 2.1 loss induces glioblastoma spreading in soft brain-like environments

Using the apparent diffusion coefficient to identifying MGMT promoter methylation status early in glioblastoma: importance of analytical method